← All diseases Cancer

Mesothelioma

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest level of evidence only (25)Meta-analysis (7)Treatment guideline (2)Systematic review (9)Phase 3 study (5)Randomized trial (2)Clinical trial (594)Review article (165)Early study (phase 1 or 2) (48)Single patient description (165)Laboratory or animal study (30)Commentary or editorial (70)Concerns have been raised (1)Retracted publication (1) Studies currently recruiting participants only (33)

Filter

Publications and studies (1698)

• Impact of asbestos on public health: a retrospective study on a series of subjects with occupational and non-occupational exposure to asbestos during the activity of Fibronit plant (Broni, Italy). (2018/12/20) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Association between mesothelioma and non-occupational asbestos exposure: systematic review and meta-analysis. (2018/12/19) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case report: Steroid responsive mesothelioma-related pleural effusion. (2018/12/19) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Photodynamic therapy and photothermal therapy for the treatment of peritoneal metastasis: a systematic review. (2018/12/18) ♡
• Diagnostics and acknowledgement of occupational diseases - topics and challenges in the Czech Republic. (2018/12/17) ♡
• Current status of cytoreductive surgery (CRS) and intraperitoneal hyperthermic chemotherapy (HIPEC) in the multimodal treatment of peritoneal surface malignancies. (2018/12/17) ♡
• Exposures estimates of the Wittenoom mining workforce and town residents - Implications associated with risk estimation for persons exposed to asbestiform riebeckite. (2018/12/15) ♡
• Calretinin Functions in Malignant Mesothelioma Cells Cannot Be Replaced by the Closely Related Ca(2+)-Binding Proteins Calbindin-D28k and Parvalbumin. (2018/12/12) ♡
• Clustering of malignant pleural mesothelioma in asbestos factories: a subgroup analysis in a 29-year follow-up study to identify high-risk industries in Taiwan. (2018/12/09) ♡
• [Peritoneal multicystic mesothelioma: report of a case]. (2018/12/08) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Role of Yes-Associated Protein (YAP) in Regulating Programmed Death-Ligand 1 (PD-L1) in Thoracic Cancer. (2018/12/07) ♡
• Heparanase inhibitors restrain mesothelioma. (2018/12/07) ♡
• Tumour associated lymphocytes in the pleural effusions of patients with mesothelioma express high levels of inhibitory receptors. (2018/12/05) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Molecular Characterization of Malignant Mesothelioma: Time for New Targets? (2018/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide. (2018/12/01) ♡
• Genomic changes of chromosomes 8p23.1 and 1q21: Novel mutations in malignant mesothelioma. (2018/12/01) ♡
• Assessment of signaling pathway inhibitors and identification of predictive biomarkers in malignant pleural mesothelioma. (2018/12/01) ♡
• BAP1 gene mutations in Egyptian patients with advanced sporadic malignant pleural mesothelioma (MPM): relation with clinical outcomes and survival. (2018/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Current developments and perspectives regarding immunotherapy in thoracic oncology. (2018/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Invited letter to the editor on the editorials on "High dose irradiation after pleurectomy/decortication or biopsy for pleural mesothelioma treatment". (2018/12/01) ♡
• The Regulatory Status Adopted by Lymph Node Dendritic Cells and T Cells During Healthy Aging Is Maintained During Cancer and May Contribute to Reduced Responses to Immunotherapy. (2018/11/30) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Systematic review of quality of life following pleurectomy decortication and extrapleural pneumonectomy for malignant pleural mesothelioma. (2018/11/29) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Biodistribution and Tumor Uptake of (67)Ga-Nimotuzumab in a Malignant Pleural Mesothelioma Xenograft. (2018/11/29) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Fluorodeoxyglucose versus Choline Positron Emission Tomography/Computed Tomography Response Evaluation in Two Malignant Pleural Mesothelioma Patients Treated with Talc Pleurodesis and Neoadjuvant Chemotherapy. (2018/11/28) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Satisfactory results of a psychometric analysis and calculation of minimal clinically important differences of the World Health Organization quality of life-BREF questionnaire in an observational cohort study with lung cancer and mesothelioma patients. (2018/11/26) ♡
• Comparison of Germline versus Somatic BAP1 Mutations for Risk of Metastasis in Uveal Melanoma. (2018/11/26) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. The significance of non-occupational asbestos exposure in women with mesothelioma. (2018/11/20) ♡
• Calretinin promotes invasiveness and EMT in malignant mesothelioma cells involving the activation of the FAK signaling pathway. (2018/11/20) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. BAP1 regulates different mechanisms of cell death. (2018/11/19) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Simultaneous presence of lung adenocarcinoma and malignant pleural mesothelioma: A case report. (2018/11/19) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Ovarian cancer in a former asbestos textile factory worker: a case report. (2018/11/16) ♡
• Learning from the past to design better trials in second-line treatment for mesothelioma patients. (2018/11/12) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Effect of the BH3 Mimetic Polyphenol (-)-Gossypol (AT-101) on the in vitro and in vivo Growth of Malignant Mesothelioma. (2018/11/06) ♡
• Macrophage Depletion in Elderly Mice Improves Response to Tumor Immunotherapy, Increases Anti-tumor T Cell Activity and Reduces Treatment-Induced Cachexia. (2018/11/06) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Interplay of non-coding RNAs and approved antimetabolites such as gemcitabine and pemetrexed in mesothelioma. (2018/11/04) ♡
• Versican modulates tumor-associated macrophage properties to stimulate mesothelioma growth. (2018/11/02) ♡
• Overall survival of pseudomyxoma peritonei and peritoneal mesothelioma patients after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy can be predicted by computed tomography quantified sarcopenia. (2018/11/01) ♡
• Safety of Same-Day Vitamin B12 Supplementation in Patients Receiving Pemetrexed for the Treatment of Non-Small-Cell Lung Cancer or Pleural Mesothelioma: A Retrospective Analysis. (2018/11/01) ♡
• Polymer coating on carbon nanotubes into Durobeads is a novel strategy for human environmental safety. (2018/11/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Lung-sparing intensity-modulated radiotherapy in malignant pleural mesothelioma: palliative or potentially radical? (2018/11/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Non-ablative hypofractionated hemithoracic radiation-a new standard of care in mesothelioma? (2018/11/01) ♡
• Pretreatment Controlling Nutritional Status Score and Lactate Dehydrogenase as Predictive Markers of Survival in Patients with Malignant Peritoneal Mesothelioma. (2018/11/01) ♡
• [All-cause mortality from 1970 to 2013 in the municipality of Trino (Piedmont region, Italy), previously home to a nuclear plant]. (2018/11/01) ♡
• Complex Immune Contextures Characterise Malignant Peritoneal Mesothelioma: Loss of Adaptive Immunological Signature in the More Aggressive Histological Types. (2018/10/29) ♡
• Virotherapy-recruited PMN-MDSC infiltration of mesothelioma blocks antitumor CTL by IL-10-mediated dendritic cell suppression. (2018/10/16) ♡
• Hybrid topoisomerase I and HDAC inhibitors as dual action anticancer agents. (2018/10/09) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Deciduoid type malignant pleural mesothelioma: a case report. (2018/10/04) ♡
• Do patients undergoing cytoreductive surgery and HIPEC for peritoneal malignancy need parenteral nutrition? (2018/10/02) ♡
• Cytology of effusions in the coelom cavities. (2018/10/01) ♡
• Management of database: European Society of Thoracic Surgeons mesothelioma database-difficulties in improving quality data for rare tumour. (2018/10/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.